FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Hospital Group Seeks FDA Actions in IV Solution Shortages

The American Hospital Association asks the Biden Administration to require FDA to take immediate actions to increase the supply of intravenous (IV) so...

latest-news-card-1
Human Drugs

Woodcock Joins Board at Drug Repurposing Nonprofit

Former FDA principal deputy commissioner Janet Woodcock joins the board of directors at Every Cure, a nonprofit organization that looks at repurposing...

latest-news-card-1
Medical Devices

Respironics Recalls Trilogy Ventilators Over Nebulizers

Philips Respironics recalls (Class 1 device correction) its Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal, and Trilogy EV300 ventilators regardin...

latest-news-card-1
Medical Devices

Medtronic Recalls MiniMed Pumps Over Batteries

Medtronic recalls (Class 1) its MiniMed Insulin pumps due to concerns about reduced battery life in certain situations.

latest-news-card-1
Medical Devices

FDA Clears PlaqueIQ for Cardiovascular Disease

An Elucid 510(k) gains clearance for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease.

latest-news-card-1
Human Drugs

Thermo Fisher Plant Scrutinized by FDA: Reuters

A Reuters article looks into drug GMP issues raised by FDA inspections over the past decade at Thermo Fisher's Greenville, NC drug contract manufactur...

latest-news-card-1
Medical Devices

CDRH Portal Update Tracks PMA Submissions

FDA updates CDRHs Customer Collaboration Portal to track the progress of PMA applications and accept Small Business Determination requests.

latest-news-card-1
Human Drugs

Drug-Drug Interaction Assessments Lacking: FDA Research

FDA says that 22% of new molecular entities required postmarketing requirements or postmarketing commitments to address knowledge gaps on drugdrug int...

latest-news-card-1
Human Drugs

J&J Discontinues Dengue Virus Antiviral Development

Johnson & Johnson discontinues a Phase 2 study evaluating mosnodenvir for preventing dengue virus in adults aged 18-65 years.

latest-news-card-1
Human Drugs

Tirzepatide Shortage Resolved, FDA Says

FDA says the shortage of Lillys Mounjaro and Zepbound has been resolved but other similar products remain in short supply.